Treatment for Subjects With Non-Hodgkin's Lymphoma

NCT00117897 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: pegfilgrastim
DRUG: Filgrastim

Sponsor

Amgen